EQSAdhoc APONTIS PHARMA AG Key word Change in ForecastProfit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and mediumterm planning for 2026 27Jul2023 2210 CETCEST Disclosure of an
APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit WarningAPONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 202627-Jul-2023 / 22:10 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service o.
EQSAdhoc APONTIS PHARMA AG Key word Change in ForecastProfit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and mediumterm planning for 2026 27Jul2023 2210 CETCEST Disclosure of an
EQS-News: APONTIS PHARMA AG / Key word: Personnel
APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as successor.